Skip to main content
CORESTEMCHEMON Inc. logo

CORESTEMCHEMON Inc. — Investor Relations & Filings

Ticker · 166480 ISIN · KR7166480004 KO Professional, scientific and technical activities
Filings indexed 274 across all filing types
Latest filing 2025-10-21 Regulatory Filings
Country KR South Korea
Listing KO 166480

About CORESTEMCHEMON Inc.

https://www.corestemchemon.com/eng/main…

CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2025-10-21 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2025-10-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2025-10-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2025-10-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2025-10-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2025-10-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.